Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Torri

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimensM G Cantù, A Buda, G Parma, et al.
British Journal of Cancer|May 20, 2004
Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the Mario Negri Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) groupA Buda, I Floriani, R Rossi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinomaL Manenti, P Paganoni, I Floriani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente)E Mari, I Floriani, A Tinazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia OncologicaG Bolis, N Colombo, S Pecorelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
Chronic oral etoposide in small-cell lung cancer: clinical and pharmacokinetic resultsC Sessa, M Zucchetti, V Torri, et al.
Anticancer Research|February 24, 2001
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patientsM Broggini, G Buraggi, A Brenna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridineE Erba, M Giordano, M Danova, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2015
Disease progression pattern in metastatic breast cancer patients treated with anti-HER2 therapiesD Serpico, L Porcu, A Tessari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patientsM Mandalà, M Reni, S Cascinu, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimensM G Cantù, A Buda, G Parma, et al.
British Journal of Cancer|May 20, 2004
Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the Mario Negri Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) groupA Buda, I Floriani, R Rossi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinomaL Manenti, P Paganoni, I Floriani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente)E Mari, I Floriani, A Tinazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia OncologicaG Bolis, N Colombo, S Pecorelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
Chronic oral etoposide in small-cell lung cancer: clinical and pharmacokinetic resultsC Sessa, M Zucchetti, V Torri, et al.
Anticancer Research|February 24, 2001
Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patientsM Broggini, G Buraggi, A Brenna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Cell kinetics of human ovarian cancer with in vivo administration of bromodeoxyuridineE Erba, M Giordano, M Danova, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2015
Disease progression pattern in metastatic breast cancer patients treated with anti-HER2 therapiesD Serpico, L Porcu, A Tessari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patientsM Mandalà, M Reni, S Cascinu, et al.
Pageof 11